Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.

Mohammad MovahediMarie-Eve BeauchampMichal AbrahamowiczDavid W RayKaleb D MichaudSofia PedroWilliam G Dixon

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2017)

GC use is a clinically important and quantifiable risk factor for DM. Risk is influenced by the dosage and treatment duration, although only for GC use within the last 6 months.

Keyphrases

cardiovascular disease
glycemic control
type diabetes
combination therapy
metabolic syndrome
high resolution
mesenchymal stem cells
insulin resistance
cell therapy